Insider Trading activities of Deciphera Pharmaceuticals, Inc. (DCPH)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Deciphera Pharmaceuticals, Inc. (DCPH) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Deciphera Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Deciphera Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is DCPH. The reporting company's CIK number is 1654151.
The total value of stock buying since 2005 is $12,750,000.
The total value of stock sales since 2005 is $26,813,313.
The total value of stock option exercises since 2005 is $836,033.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Deciphera Pharmaceuticals, Inc. (DCPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-08 0 $0 556,857 $21,340,594 181,857 $343,709
2019-06 0 $0 2,277 $57,351 2,277 $4,303
2019-05 0 $0 14,973 $346,446 14,973 $28,298
2019-02 0 $0 34,109 $966,868 58,609 $161,238
2019-01 0 $0 157,929 $4,102,054 157,929 $298,485
2017-10 750,000 $12,750,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Deciphera Pharmaceuticals, Inc. insiders (DCPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-08-16 New Leaf Bpo Associates I, L.p. (10% Owner) Sale 200,000 36.78 7,355,800
2019-08-15 New Leaf Bpo Associates I, L.p. (10% Owner) Sale 150,000 36.09 5,413,650
2019-08-13 Bristol James Arthur (Director) Sale 25,000 41.17 1,029,350
2019-08-13 Bristol James Arthur (Director) Option Ex 25,000 1.89 47,250
2019-08-13 Flynn Daniel Lee (Chief Scientific Officer) Sale 148,107 41.50 6,145,996
2019-08-13 Flynn Daniel Lee (Chief Scientific Officer) Option Ex 123,107 1.89 232,672
2019-08-13 Taylor Michael Douglas (Director) Sale 22,500 41.06 923,827
2019-08-13 Taylor Michael Douglas (Director) Option Ex 22,500 1.89 42,525
2019-08-13 Kelly Thomas Patrick (Chief Financial Officer) Sale 11,250 41.95 471,971
2019-08-13 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 11,250 1.89 21,262
2019-06-19 Kelly Thomas Patrick (Chief Financial Officer) Sale 177 25.00 4,425
2019-06-19 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 177 1.89 334
2019-06-03 Kelly Thomas Patrick (Chief Financial Officer) Sale 2,100 25.20 52,926
2019-06-03 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 2,100 1.89 3,969
2019-05-22 Kelly Thomas Patrick (Chief Financial Officer) Sale 100 25.00 2,500
2019-05-22 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 100 1.89 189
2019-05-21 Kelly Thomas Patrick (Chief Financial Officer) Sale 1,373 25.07 34,418
2019-05-21 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 1,373 1.89 2,594
2019-05-01 Kelly Thomas Patrick (Chief Financial Officer) Sale 13,500 22.93 309,528
2019-05-01 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 13,500 1.89 25,515
2019-02-21 Flynn Daniel Lee (Chief Scientific Officer) Option Ex 24,500 3.95 96,775
2019-02-19 Taylor Michael Douglas (President and CEO) Sale 3,997 30.00 119,913
2019-02-19 Taylor Michael Douglas (President and CEO) Option Ex 3,997 1.89 7,554
2019-02-19 Kelly Thomas Patrick (Chief Financial Officer) Sale 1,500 30.00 45,000
2019-02-19 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 1,500 1.89 2,835
2019-02-15 Bristol James Arthur (Director) Sale 17,782 28.04 498,607
2019-02-15 Bristol James Arthur (Director) Option Ex 17,782 1.89 33,607
2019-02-15 Taylor Michael Douglas (President and CEO) Sale 4,934 28.01 138,191
2019-02-15 Taylor Michael Douglas (President and CEO) Option Ex 4,934 1.89 9,325
2019-02-14 Bristol James Arthur (Director) Sale 1,101 28.01 30,842
2019-02-14 Bristol James Arthur (Director) Option Ex 1,101 1.89 2,080
2019-02-14 Taylor Michael Douglas (President and CEO) Sale 500 28.00 14,000
2019-02-14 Taylor Michael Douglas (President and CEO) Option Ex 500 1.89 945
2019-02-05 Bristol James Arthur (Director) Sale 2,595 28.02 72,704
2019-02-05 Bristol James Arthur (Director) Option Ex 2,595 1.89 4,904
2019-02-05 Taylor Michael Douglas (President and CEO) Sale 1,700 28.01 47,611
2019-02-05 Taylor Michael Douglas (President and CEO) Option Ex 1,700 1.89 3,213
2019-01-16 Flynn Daniel Lee (Chief Scientific Officer) Sale 152,629 26.00 3,968,354
2019-01-16 Flynn Daniel Lee (Chief Scientific Officer) Option Ex 152,629 1.89 288,468
2019-01-11 Flynn Daniel Lee (Chief Scientific Officer) Sale 300 26.00 7,800
2019-01-11 Flynn Daniel Lee (Chief Scientific Officer) Option Ex 300 1.89 567
2019-01-07 Kelly Thomas Patrick (Chief Financial Officer) Sale 5,000 25.18 125,900
2019-01-07 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 5,000 1.89 9,450
2017-10-02 New Leaf Bpo Associates I, L.p. (10% Owner) Buy 375,000 17.00 6,375,000
2017-10-02 Ratcliffe Liam (Director) Buy 375,000 17.00 6,375,000

Insider trading activities including stock purchases, stock sales, and option exercises of DCPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Deciphera Pharmaceuticals, Inc. (symbol DCPH, CIK number 1654151) see the Securities and Exchange Commission (SEC) website.